Global electronic nose market is estimated to witness growth due to rise in health issues and latest technological developments
Global electronic nose market is estimated to be valued at US$ 26.04 billion in 2024, exhibiting a CAGR of 14.2% over the forecast period (2024-2031). With widespread health concerns and increasing chronic diseases, demand for portable disease diagnostics tools has been rising. Electronic noses have emerged as reliable alternatives for detecting health issues from emitted body odors. Furthermore, ongoing technological advancements have made electronic nose systems more affordable and efficient in diagnosing diseases.
Market Dynamics:
Global electronic nose market growth is driven by rising cases of chronic diseases such as cancer and respiratory disorders that boosts demand for faster and non-invasive diagnostic methods. Electronic noses offer cost-effective and rapid odor detection capabilities to screen diseases through breath or body odor samples. Increasing R&D investments by key players to develop more accurate and miniaturized electronic nose designs have enhanced their applications across various end-use industries including healthcare, food and beverage, and environmental monitoring. Various nanomaterial-based sensing technologies are being explored to improve sensor selectivity and device portability.
Increasing demand for food safety and quality control is driving the global electronic nose market
The food and beverage industry is increasingly adopting electronic nose technology to ensure food safety and quality control. Electronic noses can detect spoilage, contamination and assist in authenticating foods in a fast, non-destructive way. These provide objective measurements of aroma, odor and volatile organic compounds which human smell fatigue can miss. This helps food manufacturers improve supply chain traceability and meet stringent regulatory standards. The technology is being used for applications like monitoring meat and fish freshness, detecting counterfeit alcoholic drinks and testing for foodborne pathogens. The demand for such advanced quality control solutions from the food industry will continue to drive the growth of the electronic nose market globally.
Growing healthcare diagnostics applications
Electronic noses are increasingly finding applications in healthcare for non-invasive diagnostics and disease detection. Their ability to detect the subtle changes in body odors associated with certain diseases makes them an attractive diagnostic tool. Researchers are exploring their potential for screening and diagnosing conditions like lung cancer, diabetes, kidney diseases and gastrointestinal disorders. Electronic nose technology is also being evaluated for identifying infectious bacteria, monitoring wound healing and improving prenatal care. As healthcare systems focus on shifting to preventive care models, demand for such innovative diagnostic approaches will increase. This presents a huge growth opportunity for electronic nose vendors to collaborate with medical research organizations and expand into clinical applications.
High production costs pose a challenge for widespread adoption
While the technology benefits are promising, the high costs associated with electronic nose R&D, manufacturing and maintenance has deterred many potential customer segments from adopting them on a large scale. Designing chemical sensors that can accurately identify thousands of volatile organic compounds is an intensive engineering challenge that pushes up costs. Additional expenditures are incurred in building specialized hardware and computational algorithms for pattern recognition. This makes electronic nose systems expensive compared to traditional analytical instruments. Their high purchase and maintenance costs continue to limit the technology to niche applications and research deployments rather than broad commercial use.
Competition from lower-cost sensing technologies acts as a restraint
Existing analytical techniques like gas chromatography–mass spectrometry (GC-MS) and infrared (IR) spectroscopy provide high-quality chemical detection at lower costs than electronic noses for many applications. While electronic noses promise portability and ease of use, they still cannot match the sensitivity and precision of laboratory-based techniques. Lower-cost chemical sensor arrays and miniaturized gas analyzers also offer competition. These alternatives are capturing market share, especially in high-volume, commodity analytical spaces. Electronic noses need to continue enhancing their sensing capabilities and analytics through ongoing R&D to stay competitive against substitutes and overcome the constraints posed by relatively higher costs.
Expanding into new application verticals opens up opportunities
While food and healthcare have seen initial success, electronic noses are now exploring adoption in broader application spaces like environmental monitoring, indoor air quality, workplace safety, manufacturing quality control, and more. The technology is being evaluated for tasks like detecting water pollution, monitoring emissions from factories and buildings, ensuring worker safety in chemical industries. Expanding beyond niche applications by innovating customized solutions for diverse industries presents significant market potential. Taking electronic nose systems to new verticals where sensing needs have been traditionally met by manual inspection or traditional instruments opens up major commercial opportunities.
Growing demand for non-invasive diagnostics will fuel market prospects
As population age and chronic diseases rise, the demand for non-invasive, affordable healthcare diagnostics is accelerating globally. Conventional diagnostics usually involve expensive and time-consuming tests which are often invasive in nature. This is where electronic nose technology can play a valuable role by providing low-cost, rapid screening tools without requiring complicated lab testing or specialized medical personnel for operation. Their ability to identify disease biomarkers from breath, skin, urine and other easily accessible samples non-invasively makes them highly suited for telemedicine, home-based monitoring and mobile healthcare applications. This ongoing trend towards effective, non-invasive diagnostics will open promising opportunities for electronic noses across diverse applications in the coming years.
Link - https://www.coherentmarketinsights.com/market-insight/electronic-nose-market-1723
Key Developments:
- In July 2023, Hell Energy, a leading energy drink producer, made history by creating the world's first energy drink entirely developed by Artificial Intelligence (AI). The company leveraged the vast amount of information and knowledge available on the internet, which AI processed at lightning speed to uncover connections and insights that would take humans years to discover.
- In May 2023, Alpha MOS, a French company specializing in electronic nose technology, announced the formal validation of its milk quality control solution by Mengniu, the largest dairy group in China and the seventh-largest globally. This validation followed a two-year framework agreement with Lan Chou Instruments, aimed at equipping Mengniu with Heracles NEO electronic noses to monitor the aroma changes in its products over time.
- In April 2023, The eNose Company, a pioneer in electronic nose technology for medical diagnostics, showcased its aeoNose device for lung cancer treatment at the HIMSS Global Health Conference and Exhibition in Chicago. The aeoNose effectively communicates with Electronic Health Records (EHR) through the company's IRIS4health Intersystems platform.
- In February 2023, Ghent University in Belgium, renowned for its research in food technology, was equipped with the HERACLES electronic nose developed by Alpha MOS, a leader in electronic nose technology. Researchers and doctoral candidates at the university utilize this advanced device to investigate innovative agri-food products intended for both human and livestock consumption. Additionally, they are exploring alternative animal feed options, leveraging HERACLES' capabilities to assess the acceptability of various feed sources, such as microbial proteins, based on their odor profiles.
- In April 2020, Intel Corporation, a leading American multinational technology company, announced a groundbreaking collaboration with Cornell University, resulting in the invention of the Loihi neuromorphic research chip. This innovative chip serves as a computer's electronic nose, enabling it to distinguish substances based on the scents or aromas they release using neuromorphic computing principles.
Key Player:
Alpha MOS, SciSens, Odotech, eNose Company, AromaBit, Sensigent, G.A.S. Gesellschaft für analytische Sensorsysteme mbH, Robosense, Nanosensors, The Good Food Institute (GFI), Kiiroo, Neotronics, Scentia, Interscience, and Flavorman
